Cullinan Therapeutics CGEM
NASDAQ CGEM
$15.23 +0.01 (+0.03%)
As of: Sep 30, 2026 · 10:25 AM EDT

Cullinan Therapeutics (CGEM) Other financing activities (2021 - 2024)

Updated

Cullinan Therapeutics (CGEM) recorded Other financing activities of $4.45 million in FY2024.

Analysis

Cullinan Therapeutics (CGEM) Other financing activities (2021 - 2024) Analysis & Trends

  • Annual Other financing activities has a four-year compound annual growth rate of 38.6% (FY2020 to FY2024).
  • The FY2024 figure is the lowest annual Other financing activities since FY2020.
  • Per Business Quant data, CGEM's Other financing activities was $33.28 million in FY2022 and $1.21 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Cullinan Therapeutics 961.97 Mn 961.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 656,000.00
Jun 30, 2024 3.79 Mn
Dec 31, 2022 32.13 Mn
Jun 30, 2022 1.13 Mn
Mar 31, 2022 22,000.00
Dec 31, 2021 -923,000.00
API Access

Cullinan Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=CGEM&period=max&api_key=YOUR_API_KEY